Axcelis Technologies, Inc. (NASDAQ:ACLS – Get Free Report) EVP Eileen Evans sold 926 shares of the company’s stock in a transaction that occurred on Friday, May 22nd. The stock was sold at an average price of $155.51, for a total transaction of $144,002.26. Following the transaction, the executive vice president owned 31,295 shares in the company, valued at $4,866,685.45. The trade was a 2.87% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.
Axcelis Technologies Price Performance
Shares of ACLS stock traded up $4.43 during trading hours on Friday, reaching $156.94. 476,936 shares of the company were exchanged, compared to its average volume of 773,529. Axcelis Technologies, Inc. has a fifty-two week low of $55.93 and a fifty-two week high of $171.61. The stock’s fifty day moving average is $119.70 and its two-hundred day moving average is $97.89. The company has a market cap of $4.82 billion, a price-to-earnings ratio of 48.89, a P/E/G ratio of 11.91 and a beta of 1.93. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.59 and a quick ratio of 2.99.
Axcelis Technologies (NASDAQ:ACLS – Get Free Report) last announced its earnings results on Thursday, May 7th. The semiconductor company reported $0.72 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.71 by $0.01. Axcelis Technologies had a net margin of 11.93% and a return on equity of 12.19%. The company had revenue of $198.96 million for the quarter, compared to analyst estimates of $195.03 million. During the same period in the prior year, the business earned $0.88 earnings per share. Axcelis Technologies’s quarterly revenue was up 3.3% on a year-over-year basis. Axcelis Technologies has set its Q2 2026 guidance at 0.900- EPS. Sell-side analysts forecast that Axcelis Technologies, Inc. will post 2.86 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Axcelis Technologies
Analyst Ratings Changes
ACLS has been the topic of a number of research reports. Zacks Research upgraded shares of Axcelis Technologies from a “strong sell” rating to a “hold” rating in a research report on Monday, April 20th. Weiss Ratings lowered shares of Axcelis Technologies from a “hold (c)” rating to a “hold (c-)” rating in a report on Tuesday, May 12th. Finally, B. Riley Financial upgraded shares of Axcelis Technologies from a “neutral” rating to a “buy” rating and set a $150.00 price objective on the stock in a report on Monday, April 20th. Three investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $116.25.
Check Out Our Latest Analysis on Axcelis Technologies
About Axcelis Technologies
Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.
The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.
Featured Articles
- Five stocks we like better than Axcelis Technologies
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
